← FDA Drug Approvals (Drugs@FDA)

BAQSIMI

NDA · New Drug Application · Sponsor: AMPHASTAR PHARMS INC · Approved 2019-07-24

Drug application

FDA Application #

NDA210134

Application type

New Drug Application

Brand name

BAQSIMI

Generic name

GLUCAGON

Active ingredients

GLUCAGON

Dosage form

POWDER

Route

NASAL

Marketing status

Prescription

Sponsor

AMPHASTAR PHARMS INC

Manufacturer

Amphastar Pharmaceuticals, Inc.

First approval

2019-07-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown